088264552 | sch | 39713635 | | 2984570 | 1/9/2006 12:00:00 am | l carotid artery stent | | dis | admission date: 2/29/2006 report status:discharge date: 6/4/2006 final discharge orders renteria , alberto e. 031-08-99-2inggopringsservice: cardischarge patient on: 5/18/06 at 12:00 pmcontingent upon attending evaluationwill d/c order be used as the d/c summary: yesattending: budesa , junior c. , m.d.code status:full codedisposition: home w/ servicesdischarge medications:plavix ( clopidogrel ) 75 mg po dailyinstructions: starting todayneoral cyclosporine ( cyclosporine micro ( neoral ) )75 mg po bid food/drug interaction instructionavoid grapefruit unless md instructs otherwise.give with mealsoverride notice: override added on 2/12/06 bygregoroff , wallace , m.d.on order for pravachol po ( ref # 213792596 )potentially serious interaction: cyclosporine &pravastatin sodium reason for override: md awarecolace ( docusate sodium ) 100 mg po bid prn constipationenteric coated asa 325 mg po dailypepcid ( famotidine ) 20 mg po bidinstructions: resume zantac 150mg bid at dischargeferrous sulfate 325 mg po tidfood/drug interaction instruction avoid milk and antacidfurosemide 40 mg po dailyglyburide 10 mg po qamlantus ( insulin glargine ) 20 units sc qamstarting in am on 5/13toprol xl ( metoprolol succinate extended release )50 mg po daily hold if: sbp < 100 , hr < 55food/drug interaction instructiontake consistently with meals or on empty stomach.number of doses required ( approximate ): 2cellcept ( mycophenolate mofetil ) 1 , 000 mg po bidfood/drug interaction instructiongive on an empty stomach ( give 1hr before or 2hr afterfood ) food decreases peak by up to 40%nabumetone 500 mg po bidfood/drug interaction instruction take with foodpravachol ( pravastatin ) 20 mg po bedtimefood/drug interaction instructionavoid grapefruit unless md instructs otherwise.alert overridden: override added on 2/12/06 byemami , hollis , m.d.on order for pravachol po ( ref # 213792596 )pt. has a probable allergy to simvastatin; reaction ismuscle aches. reason for override: patient requiresprevious alert overriddenoverride added on 2/12/06 by ybos , clifford , m.d.potentially serious interaction: cyclosporine &pravastatin sodium reason for override: md awareprednisone 6 mg po qamdiet: house / ada 2100 cals/dyactivity: walking as toleratedfollow up appointment( s ):rheumatology: dr. yoakum , 8540664703 2 months time ,please call your pcp dr. wardian for an appointment within 1-2 weeks of discharge ( 067-002-8011 ) , and she may refer you for further diabetes care ,allergy: simvastatinadmit diagnosis:l carotid artery stentprincipal discharge diagnosis ;responsible after study for causing admission )l carotid artery stentother diagnosis;conditions , infections , complications , affecting treatment/stays/p cardiac transplant 1992 ( s/p cardiac transplant ) diabetes mellitustype ii ( diabetes mellitus type 2 ) trochanteric bursitis ( trochantericbursitis ) dyslipidemia ( dyslipidemia ) djd spine ( oa of cervicalspine ) hx vocal cord injury postop hx gastritis with ugib ( h/o uppergi bleeding ) hx postop seizureoperations and procedures:left carotid artery stent placement.other treatments/procedures ( not in o.r. )none.brief resume of hospital course:hpi: ms. phetteplace is a 70 yo woman with h/o cardiac transplant 1992 , s/ppci/stent 6/19 with 80% lesion lcx s/p r carotid stent placement 6/19 ,h/o dm , htn , hyperlipidemia , smoking , now s/p l carotid stent placement10/24/06 .  during annual follow up in 9/30 of her heart transplant , acomplex eccentric 80% lesion was noted in the proximal lcx. she wasadmitted in january electively with plans for cardiac cath/pci/stent.however in the interim period , she had a symptomatic lue numbness thoughtto be a tia , concerning for r carotid stenosis.an mri revealed bilateraltight carotid stenosis. the lcx and symptomatic r carotid arteryunderwent cath/stent placement in 6/19 .  however , intervention on herleft internal carotid artery ( though 90% occluded by cath ) was deferreddue to already receiving 2 angiographikc procedures during the 6/19admission. at this time she was tapered off cell-cept and started onrapamycin - in hopes of slowing progression in her coronary disease. shethen returned to medical attention on 19 of april for catheterization/stentplacement on left carotid artery. during these procedure , a hematomadeveloped at the l femoral access site which was managed with compressionduring the case. fsbs was 384 prior to the procedure and elevated to 547during the procedure ( she received d5w+hco3 during the procedure. ) shewas given 10 u regular insulin x 2 and her fsbs declined to 400s. herpost-procedure course has been complicated by hyperglycemia and hematomaformation with a hct drop of 30 ` 22.pmh:1.	tia patient taken to cath lab after rue numbness c/w tia 6/19 .bilateral carotid stenoses were seen by angiography. stenting of rinternal carotid artery performed2.	cad: coronary angiography/pci of lcx lesion. cypher stent.discharged on asa/plavix.3.	heart transplant recipient: 1992 2/2 end stage ischemiccardiomyopathy. was switched from cellcept and cyclosporine torapamycin/cyclosporine during 6/19 admission because of concern ofprogression of coronary disease within the allograft. last echo 1/17lv sized decrease , normal overall function. ef 65%. no rwma. rv nlsize/thickness/function. severe lae/mild rae c/w transplant. no changefrom 10/4 study.4.	hypercholesterolemia5.	djd spine6.	type ii dm since 19927.	gastritis8.	h/o gibmeds on admission: rapamune 1 mg bid , prednisone 6 mg qday , metoprolol50 mg po qday , zantac 150 mg po bid , nabumetone 750 qday , glyburide 5 mgbid , ditropan 10 mg po qday , plavix 75 mg po qday , zetia 10 mg po qday ,lasix 40 mg po qday , tums po tid , ecasa 325 , magnesium 400 mg po qday ,multivit , cyclosporine 50 mg po bid , tricor 48 mg po qdaysoc hx: exsmoker and drinks wine occassionally. she lives alone.all: prior intolerance of statins ( full body aches ) and zetia ( muscularaches ).exam on 5/25/06vitals - afebrile 96/52 95no jvd , neck supple , ctab , distant heart sounds rrr. no m/r/gappreciated , soft nt/nd. r groin- ecchymosis , no marked swelling/hematomaat site.extremities: tr edema , +1 pulses dp/at bilaterally.assessment: ms. poehlein is a 70 yo woman with h/o cardiac transplant1992 , s/p pci/stent 6/19 with 80% lesion lcx s/p r carotid stentplacement 6/19 , h/o dm , htn , hyperlipidemia , smoking , now s/p l carotidstent placement 10/24/06 with postprocedure course complicated by hematomaformation causing acute on chronic anemia , and hyperglycemia.labs/studies:chol: chol 354 , tg 1383 , hdl 29 ( up from 4/11 chol 267 , tg 677 , hdl 29 )hba1c 11.1 ( up from 10/18 6.9 )1. heme: patient had r femoral hematoma due to bleeding around sheath andcausing fluctuation in hct. hct currently stable without transfusions.site non-pulsatile and no bruits. transfusing 1 u prbc 6/20 for goalhct>28.2. cv( ischemia ): patient h/o ischemic cm s/p heart transplant withevidence of cad on allograft. patient medically managed with pravachol ,aspirin and plavix. now s/p bilateral carotid stents and stent to lcx.attempt to change immunosuppressive regiments to rapamycin in order tolower progression of cad however on this regiment , her cholesterol panelhas markedly worsened. have stopped rapamycin ( 6/20 ) and restartingcellcept and cyclosporine at prior doses. will need review in clinic in30 days with bilateral carotid ultrasounds.cv( pump ): clinically appears euvolemic. on toprol , restarting lasix athome dose ( 5/13 ).cv( rhythm ): on telemetry , no events seen.3. endo: during hospitalization and prior/during procedures has had poorglucose controls with fsbs in 300s-400s. patient reports poor glycemiccontrol at home with fsbs in 300s. am fsbs was 384 and received d5nsprior to procedure , exacerbating hyperglycemia. endocrinconsulted andrecommended qday lantus injection with with novolog sliding scale + acwhile in house. hba1c @ 11 ( markedly worse than 6 in january ) - patient cannot identify other factors which have changed since january other thanimmunosuppressants to rapamycin. fsbs were difficult to control in housedespite using 20 qday of lantus , ms. nickodem fsbs continued to run inthe 200s-300s during the day. she was taught to inject herself withinsulin sc during her stay. she is discharged on glyburide 10 qday andlantus 20 qday. she was taught to keep a diary and will follow up with herpcp.4. neuro: tia/cva in 6/19 .  residual left numbness/weakness in hand. onplavix and asa , now s/p r and l carotid stents.5. immunosuppression: as above , have changed immunosuppression fromrapamycin + cyclosporine back to cyclosporine 75 bid +cellcept 1000 bid aspatient performed priorto 6/19 .6. msk/rheum: the patient previously complained of myalgias with statins andwas resistant to starting statins because they seemed to worsen heraches/pains. rheumatology service was consulted. they believed her painis not consistent with statin associated myalgia. zetia was stopped andshe was started on pravachol 20 mg qhs.her back pain is relieved by leaning forward and she walks at arkansaswith a shopping cart for exercise which is consistent with spinal stenosis.they recommended physical therapy and mri imaging of her back. the mripreliminary read shows multilevel degenerative disc disease and moderatespinal stenosis at one level. physical therapy saw her and thought shewould benefit from home pt in the future--she was given a prescription foroutpatient physical therapy.since she is on long term prednisone she should have a dexa scan and maybenefit from bisphosphonate therapy.discharge medication: cellcept 1000 mg bid , lantus 20 sc qam , nabumetone 500mg po bid , pravachol 20 mg po qhs , glyburide 10 mg po qam , cyclosporine 75mg po bid , toprol 50 mg po qday , prednisone 6 mg po qam , plavix 75 po qday ,zantac 150 mg bid , furosemide 40 mg po qday , fe 325 po tid , ecasa 325 poqdayadditional comments:discharge condition: satisfactoryto do/plan:[x] follow up lumbar mri results for question of spinal stenosis.[] follow up a1c with lantus and have glucose monitoring diary.[] carotid dopplers in 1 months timeno dictated summaryentered by: mccandless , wayne c. , m.d. ( pn70 ) 5/18/06 @ 09:32 am end of discharge orders 